刺激多巴胺2型受体可降低人眼内压。
Stimulation of dopamine receptors (type 2) lowers human intraocular pressure.
作者信息
Mekki Q A, Turner P
出版信息
Br J Ophthalmol. 1985 Dec;69(12):909-10. doi: 10.1136/bjo.69.12.909.
Abstract
The interaction between bromocriptine and metoclopramide on intraocular pressure (IOP), pupil diameter, and other parameters were studied in healthy volunteers. Pupil diameter was not affected by both treatments and only bromocriptine lowered IOP. Prior treatment with metoclopramide blocked the IOP-lowering effect of bromocriptine. It is concluded that bromocriptine lowers IOP by stimulation of dopamine-2 receptors.
摘要
在健康志愿者中研究了溴隐亭与甲氧氯普胺对眼压（IOP）、瞳孔直径及其他参数的相互作用。两种治疗均未影响瞳孔直径，只有溴隐亭降低了眼压。预先用甲氧氯普胺治疗可阻断溴隐亭的降眼压作用。得出的结论是，溴隐亭通过刺激多巴胺2受体降低眼压。
相似文献
1
Stimulation of dopamine receptors (type 2) lowers human intraocular pressure.刺激多巴胺2型受体可降低人眼内压。
Br J Ophthalmol. 1985 Dec;69(12):909-10. doi: 10.1136/bjo.69.12.909.
2
The effects of dopamine, haloperidol and bromocriptine on intraocular pressure.
Int Ophthalmol. 1992 Sep;16(4-5):343-7. doi: 10.1007/BF00917988.
3
Bromocriptine lowers intraocular pressure without affecting blood pressure.溴隐亭可降低眼压而不影响血压。
Lancet. 1983 Jun 4;1(8336):1250-1. doi: 10.1016/s0140-6736(83)92699-5.
4
Effect of changes in the plasma ACTH level on the prolactin response to metoclopramide or bromocriptine in normal subjects and patients with Nelson's syndrome.正常受试者和尼尔森综合征患者血浆促肾上腺皮质激素（ACTH）水平变化对甲氧氯普胺或溴隐亭催乳素反应的影响。
Horm Metab Res. 1984 Feb;16(2):107-8. doi: 10.1055/s-2007-1014712.
5
Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.甲氧氯普胺诱导的人体醛固酮分泌的多巴胺能抑制作用。对多巴胺和溴隐亭反应的解离。
J Clin Invest. 1980 Jul;66(1):10-8. doi: 10.1172/JCI109822.
6
Effect of bromocriptine and metoclopramide on serum prolactin levels in patients with amyotrophic lateral sclerosis.溴隐亭和胃复安对肌萎缩侧索硬化症患者血清催乳素水平的影响。
J Neurol Neurosurg Psychiatry. 1988 May;51(5):643-5. doi: 10.1136/jnnp.51.5.643.
7
A preliminary study of the ocular hypotensive effects of bromocriptine in diabetic patients with autonomic neuropathy.溴隐亭对糖尿病自主神经病变患者眼压降低作用的初步研究。
Postgrad Med J. 1991 Apr;67(786):347-9. doi: 10.1136/pgmj.67.786.347.
8
Effects of dopamine D-1 and D-2 receptors on intraocular pressure in conscious rabbits.多巴胺D-1和D-2受体对清醒家兔眼压的影响。
J Neural Transm (Vienna). 1997;104(2-3):111-23. doi: 10.1007/BF01273174.
9
Antagonism of bromocriptine-induced cage climbing behaviour in mice by the selective D-2 dopamine receptor antagonists, metoclopramide and molindone.
Indian J Physiol Pharmacol. 1986 Jan-Mar;30(1):85-90.
引用本文的文献
1
Intraocular pressure changes during sexual activity.在性行为过程中眼压的变化。
Acta Ophthalmol. 2013 Jun;91(4):e324-5. doi: 10.1111/aos.12023. Epub 2013 Apr 23.
2
Effects of dopamine D-1 and D-2 receptors on intraocular pressure in conscious rabbits.多巴胺D-1和D-2受体对清醒家兔眼压的影响。
J Neural Transm (Vienna). 1997;104(2-3):111-23. doi: 10.1007/BF01273174.
3
Bromocriptine, dopamine and glaucoma.溴隐亭、多巴胺与青光眼
Postgrad Med J. 1986 Sep;62(731):819-20. doi: 10.1136/pgmj.62.731.819.
4
The effect of a single oral dose of pergolide on intraocular pressure and pupil diameter.单次口服培高利特对眼压和瞳孔直径的影响。
Br J Clin Pharmacol. 1989 Sep;28(3):263-8. doi: 10.1111/j.1365-2125.1989.tb05425.x.
5
The effects of lisuride, terguride and bromocriptine on intraocular pressure (IOP).利苏瑞肽、特古瑞肽和溴隐亭对眼压（IOP）的影响。
Br J Clin Pharmacol. 1989 Feb;27(2):159-63. doi: 10.1111/j.1365-2125.1989.tb05346.x.
6
A comparison of the ocular hypotensive effect of 0.025% bromocriptine and 0.25% timolol eye drops in normal human volunteers.0.025%溴隐亭滴眼液与0.25%噻吗洛尔滴眼液对正常人类志愿者的降眼压效果比较。
Br J Clin Pharmacol. 1989 Oct;28(4):443-7. doi: 10.1111/j.1365-2125.1989.tb03525.x.
7
Antagonism by domperidone of the ocular hypotensive effect of pergolide.多潘立酮对培高利特眼压降低作用的拮抗作用。
Eur J Clin Pharmacol. 1990;38(5):461-3. doi: 10.1007/BF02336684.
8
A preliminary study of the ocular hypotensive effects of bromocriptine in diabetic patients with autonomic neuropathy.溴隐亭对糖尿病自主神经病变患者眼压降低作用的初步研究。
Postgrad Med J. 1991 Apr;67(786):347-9. doi: 10.1136/pgmj.67.786.347.
9
Elevated prolactin levels in human aqueous humor of patients with anterior uveitis.
Graefes Arch Clin Exp Ophthalmol. 1991;229(5):447-51. doi: 10.1007/BF00166308.
10
The effects of dopamine, haloperidol and bromocriptine on intraocular pressure.
Int Ophthalmol. 1992 Sep;16(4-5):343-7. doi: 10.1007/BF00917988.
本文引用的文献
1
A noninvasive tonometer in the measurement of the effects of pindolol and timolol on intraocular pressure in normal subjects.一种用于测量吲哚洛尔和噻吗洛尔对正常受试者眼压影响的非侵入性眼压计。
Br J Ophthalmol. 1981 Aug;65(8):536-8. doi: 10.1136/bjo.65.8.536.
2
Metoclopramide. An updated review of its pharmacological properties and clinical use.甲氧氯普胺。对其药理特性及临床应用的最新综述。
Drugs. 1983 May;25(5):451-94. doi: 10.2165/00003495-198325050-00002.
3
Bromocriptine eyedrops lower intraocular pressure without affecting prolactin levels.溴隐亭滴眼液可降低眼压，且不影响催乳素水平。
Lancet. 1984 Feb 4;1(8371):287-8. doi: 10.1016/s0140-6736(84)90162-4.
4
Bromocriptine lowers intraocular pressure without affecting blood pressure.溴隐亭可降低眼压而不影响血压。
Lancet. 1983 Jun 4;1(8336):1250-1. doi: 10.1016/s0140-6736(83)92699-5.
5
Alpha-adrenolytic properties of bromocriptine in dogs.溴隐亭对犬的α-肾上腺素能阻断特性
Arch Int Pharmacodyn Ther. 1982 Nov;260(1):83-90.
6
A new tonometer system.
Am J Optom Arch Am Acad Optom. 1972 Aug;49(8):646-60. doi: 10.1097/00006324-197208000-00005.
7
A behavioural and biochemical comparison of dopamine receptor blockade produced by haloperidol with that produced by substituted benzamide drugs.
Life Sci. 1978 Aug 14;23(6):545-9. doi: 10.1016/0024-3205(78)90032-2.
Zotero 插件